SCHEMBL16159274

SCHEMBL16159274

c1ccc2cc(-c3ccc4c(-c5ccc(-c6cnco6)cc5)c5ccccc5c(-c5ccc(-c6cnco6)cc5)c4c3)ccc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.68
CYP11B2 P19099 2/20 0.68
LMNA P02545 2/20 0.43
PKM P14618 2/20 0.43
NOTUM Q6P988 1/20 0.43
GAA P10253 1/20 0.43
PTK2 Q05397 1/20 0.41
CYP17A1 P05093 1/20 0.41
CYP19A1 P11511 1/20 0.41
LTA4H P09960 1/20 0.40
KEAP1 Q14145 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
MAP4K4 O95819 1/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
POLB P06746 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17704315 0.91 CYP11B1 (0.68) CYP11B1CYP11B2LMNAPKMNOTUM
SCHEMBL17704410 0.91 CYP11B1 (0.63) CYP11B1CYP11B2LMNAPKMNOTUM
SCHEMBL16159273 0.87 CYP11B1 (0.49) CYP11B1CYP11B2LMNAPKMNOTUM
SCHEMBL16159332 0.87 CYP11B1 (0.49) CYP11B1CYP11B2LMNAPKMNOTUM
SCHEMBL16159421 0.86 CYP11B1 (0.57) CYP11B1CYP11B2CYP17A1CYP19A1KMT2A
SCHEMBL16159322 0.85 CYP11B1 (0.47) CYP11B1CYP11B2LMNAPKMNOTUM
SCHEMBL16159324 0.85 KMT2A (0.47) CYP11B1CYP11B2LMNAPKMNOTUM
SCHEMBL17704396 0.85 CYP11B1 (0.58) CYP11B1CYP11B2LMNAPKMNOTUM
SCHEMBL16159323 0.85 CYP11B1 (0.48) CYP11B1CYP11B2LMNAPKMNOTUM
SCHEMBL17704435 0.84 CYP11B1 (0.54) CYP11B1CYP11B2LMNAPKMPTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC CORPORATION (JP) 2016-04-28 US disclosed
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC CORPORATION (JP) 2016-04-28 US disclosed
WO-2014163173-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC株式会社 (JP) 2014-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME HVCN1, VDAC1, SLC26A3 CYP11B1 312/4885CYP11B2 420/4885LMNA 940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.